Fourth Annual Chicago Supportive Oncology Conference

Community Oncology

Volume 4, Number 5 (May 2007)

Letter from the Editor

270

 

Clinical and administrative issues: keeping current, changing hats

Lee S. Schwartzberg, MD, FACP, Editor-in-Chief

The West Clinic, Memphis, TN

As community-based oncologists, we wear many hats and must stay on top of the latest clinical data as well as practice expenses. As always, this month’s issue helps keep us abreast of new developments in both arenas.

full text 43 kb

Original Contribution

277

 

Evaluating adjuvant hormonal therapy in early-stage breast cancer: a comparison of predictive decision models

Edgardo Rivera, MD

Methodist Hospital System, Weill Cornell University, Houston, TX

In this review, the author discusses potential applications as well as limitations of two current predictive models of optimal treatment strategies for adjuvant endocrine therapy for postmenopausal women with hormone-receptor–positive, early-stage breast cancer.

abstract full text 108 kb

Community Translations

290

 

Bevacizumab: antiangiogenic success story

Now recognized as the fourth modality of cancer treatment, antiangiogenic therapy has had a long and sometimes bumpy history. An update, with various viewpoints, including the perspective of the field’s leading champion and pioneer, Judah Folkman, MD.

 

FROM THE COMMUNITY ONCOLOGIST'S PERSPECTIVE
Bevacizumab’s role in treating advanced colorectal cancer

Matthew P. Jones, MD

West Virginia University Hospital-East, Martinsburg, WV

 

FROM THE PERSPECTIVE OF A PIONEER IN THE FIELD
Angiogenic inhibitors: a fourth modality of anticancer therapy

Judah Folkman, MD

Children’s Hospital of Boston and Harvard Medical School, Boston, MA

 

FROM THE NURSE'S PERSPECTIVE
Adding bevacizumab to our protocols has improved patient outcomes with little added risk

Andrea Hartman RN, OCN, and Tamara M. Ware, MSN, RN, BC, OCN®

City Hospital, a member of West Virginia University Hospitals-East, Martinsburg, WV

full text 169 kb

Economics/Practice Management

311

 

EMR update: part 1
Crossing the digital Rubicon: committing to electronic medical record systems

Peter J. Tarr, PhD

The technology is now more secure and more efficient than ever, yet most oncology practices have still not joined the digital age. If you are in that boat, this article and its companion on page 316 could be the last things you need to read before taking the plunge.

 

FROM THE EDITOR'S DESK
An EMR story

David H. Henry, MD

Pennsylvania Hospital, Philadelphia

316

 

EMR update: part 2
Choosing, installing, and supporting an EMR system

Peter J. Tarr, PhD

You’ve made the decision to make the leap. Now what? In Part 2 of our report on electronic medical records, we guide you through the steps you need to take and the questions you need to ask along the way as you make this important purchase.

full text 170 kb

Controversies in Patient Care

331

 

Pregnancy after breast cancer

Nabiel Alkhouri, MD, Pasquale Patrizio, MD, MBE, and Jame Abraham, MD

Mary Babb Randolph Cancer Center and West Virginia University, Morgantown, WV, and Yale University Medical School, New Haven, CT

Premenopausal women with breast cancer still desire pregnancy. This article focuses on their risk of breast cancer recurrence and mortality. Evidence is growing that a subsequent pregnancy will not adversely affect their survival, although it is prudent to wait 2 years after diagnosis.

 

COMMENTARY
Fertility and breast cancer: the issues

Richard L. Theriault, DO

The University of Texas M. D. Anderson Cancer Center, Houston, TX

 

FROM THE EDITOR'S DESK
Counseling patients on pregnancy after breast cancer: arming yourself with the facts

Linda D. Bosserman, MD, FACP

Wilshire Oncology Medical Group, Inc., La Verne, CA

abstract full text 220 kb

Nursing Management

350

 

Telephone contacts between triage nurses and cancer patients: an integral part of a community oncology practice

Victoria C. Lucia, PhD, Veronica B. Decker, APRN, BC, MBA, Cynthia E. Israel, RN, OCN, and David A. Decker, MD

Research Institute, William Beaumont Hospital, Royal Oak, MI; Cancer Care Associates, Royal Oak, MI; and William Beaumont Hospital, Royal Oak, MI

Telephone contacts between triage nurses and patients seen in a community oncology office are an integral part of healthcare coverage. These calls focus on everyday concerns, such as pain management and chemotherapy side effects. They alert nurses to early signs of cancer recurrence. Although these telephone contacts are not a reimbursable expense, they provide a service that often helps avoid the high cost of an emergency room visit or hospitalization.

 

FROM THE EDITOR'S DESK
Telephone management: a reimbursable expense?

Linda D. Bosserman, MD, FACP

Wilshire Oncology Medical Group, Inc., La Verne, CA

abstract full text 102 kb

Washington Update

301

 

New legislation would add pay for planning services

Joel B. Finkelstein

Legislation recently introduced in the House of Representatives would require Medicare to immediately start paying oncologists for drafting treatment plans and summaries and provide new funding for symptom management education.

full text 44 kb

Technology

326

 

I hear a voice: using speech-recognition systems in community practice

John J. Fried

A computer program that can turn the specialized speech of doctors into written text is proving to be a valuable practice too.

full text 57 kb

© 2007 by Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.